The pharma industry is undergoing a disruption that will severely impact the way companies interact with their customers and patients. There are 5 key trends that we observe in the industry:
Acceleration of telehealth: Did COVID-19 act as an accelerator of telehealth and will it become a standard in care? How should organizations modify their offering to physicians in light of increased importance of telehealth?
Abundance of healthcare data: The global healthcare data has grown by 10x in the past 10 years – what can be a pharmacoćs business model for using it? What capabilities do pharmacos need to develop? What are the regulatory guidelines to use data in pharma?
Artificial Intelligence: Technologies based on AI are re-inventing all other industries (e.g., banking, retail) / how can AI fundamentaly change healthcare delivery and the way pharmacos create value?
Digitalization of communication experience: How can a pharmaco create a seamless experience for its HCPs? How to get closer to patients to support treatment? How to meet ever increasing expectations from HCPs while minimizing disruption?
Decentralization of healthcare: Will healthcare be more decentralized in the future? Can we expect more inpatient care to happen in smaller clinics or even at patients’ homes?
While we have seen a significant increase in digitalization within pharma during COVID-19 pandemic, especially when it comes to customer engagement, pharma is still lagging in terms of digital capabilities behind most industries (e.g., insurance, banking, media, telecoms, retail, travel/hospitality). This means that the early movers in digital have potentially larger opportunities than the followers.